Goldman Sachs’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$181M Buy
863,916
+95,581
+12% +$24M 0.02% 722
2025
Q4
$218M Buy
768,335
+10,523
+1% +$3.29M 0.03% 605
2025
Q3
$234M Sell
757,812
-231,077
-23% -$72.4M 0.03% 545
2025
Q2
$311M Buy
988,889
+409,587
+71% +$118M 0.04% 420
2025
Q1
$152M Buy
579,302
+27,028
+5% +$7.31M 0.02% 607
2024
Q4
$144M Sell
552,274
-329,509
-37% -$83M 0.02% 633
2024
Q3
$205M Sell
881,783
-44,057
-5% -$9.05M 0.03% 514
2024
Q2
$187M Buy
925,840
+119,965
+15% +$21.6M 0.03% 524
2024
Q1
$138M Sell
805,875
-72,654
-8% -$13.5M 0.02% 622
2023
Q4
$191M Buy
878,529
+316,649
+56% +$54.3M 0.04% 505
2023
Q3
$89.6M Buy
561,880
+46,607
+9% +$10.4M 0.02% 774
2023
Q2
$149M Sell
515,273
-27,518
-5% -$8.36M 0.03% 545
2023
Q1
$173M Sell
542,791
-59,183
-10% -$17.5M 0.04% 476
2022
Q4
$177M Sell
601,974
-66,479
-10% -$18.3M 0.04% 463
2022
Q3
$153M Buy
668,453
+51,763
+8% +$13M 0.04% 495
2022
Q2
$134M Buy
616,690
+30,411
+5% +$6.91M 0.03% 544
2022
Q1
$156M Sell
586,279
-11,911
-2% -$2.92M 0.03% 527
2021
Q4
$159M Buy
598,190
+33,426
+6% +$9.7M 0.03% 554
2021
Q3
$161M Sell
564,764
-18,865
-3% -$5.38M 0.03% 497
2021
Q2
$160M Buy
583,629
+32,716
+6% +$8.89M 0.04% 495
2021
Q1
$144M Buy
550,913
+2,964
+0.5% +$794K 0.04% 479
2020
Q4
$140M Sell
547,949
-105,178
-16% -$26.1M 0.04% 458
2020
Q3
$155M Buy
653,127
+96,045
+17% +$20.2M 0.04% 405
2020
Q2
$108M Buy
557,082
+137,056
+33% +$26.2M 0.03% 521
2020
Q1
$69.6M Buy
420,026
+256,789
+157% +$46.9M 0.02% 665
2019
Q4
$27.9M Sell
163,237
-183,199
-53% -$30.5M 0.01% 1586
2019
Q3
$57.1M Sell
346,436
-94,534
-21% -$13.3M 0.02% 1027
2019
Q2
$52.6M Sell
440,970
-201,801
-31% -$20.7M 0.02% 1097
2019
Q1
$61.1M Buy
642,771
+348,643
+119% +$29.9M 0.02% 964
2018
Q4
$23.3M Buy
294,128
+92,859
+46% +$7.86M 0.01% 1691
2018
Q3
$21.3M Sell
201,269
-89,800
-31% -$8.41M 0.01% 1860
2018
Q2
$24.9M Buy
291,069
+248,038
+576% +$22.2M 0.01% 1720
2018
Q1
$3.73M Sell
43,031
-26,553
-38% -$2.06M ﹤0.01% 3125
2017
Q4
$4.8M Buy
69,584
+11,597
+20% +$761K ﹤0.01% 3047
2017
Q3
$3.19M Sell
57,987
-73,994
-56% -$4.04M ﹤0.01% 3559
2017
Q2
$6.77M Sell
131,981
-60,621
-31% -$2.63M ﹤0.01% 2818
2017
Q1
$8.3M Sell
192,602
-50,270
-21% -$2.16M ﹤0.01% 2544
2016
Q4
$9.15M Sell
242,872
-198,431
-45% -$7.39M ﹤0.01% 2535
2016
Q3
$18.1M Buy
441,303
+296,788
+205% +$11.7M 0.01% 1968
2016
Q2
$4.37M Buy
144,515
+74,165
+105% +$2.31M ﹤0.01% 2975
2016
Q1
$2.33M Buy
70,350
+27,784
+65% +$872K ﹤0.01% 3335
2015
Q4
$1.61M Buy
42,566
+3,934
+10% +$132K ﹤0.01% 3830
2015
Q3
$1M Sell
38,632
-10,745
-22% -$326K ﹤0.01% 4486
2015
Q2
$1.53M Sell
49,377
-109,802
-69% -$3.24M ﹤0.01% 4122
2015
Q1
$5.31M Buy
159,179
+128,187
+414% +$4.33M ﹤0.01% 2831
2014
Q4
$1.43M Sell
30,992
-37,180
-55% -$1.59M ﹤0.01% 4198
2014
Q3
$2.51M Buy
68,172
+9,768
+17% +$357K ﹤0.01% 3709
2014
Q2
$2.32M Sell
58,404
-178,900
-75% -$6.88M ﹤0.01% 3843
2014
Q1
$11.3M Buy
237,304
+68,026
+40% +$3.01M ﹤0.01% 2272
2013
Q4
$6.28M Buy
169,278
+52,416
+45% +$1.94M ﹤0.01% 2821
2013
Q3
$4.24M Sell
116,862
-52,140
-31% -$1.75M ﹤0.01% 3119
2013
Q2
$5.31M Buy
+169,002
New +$4.79M ﹤0.01% 2672

Other funds holding PODD

Goldman Sachs's PODD Position: Q1 2026 in Review

Goldman Sachs increased its Insulet (PODD) stake by 12% in Q1 2026, buying an estimated $24M and bringing the position to 863,916 shares worth $181M. The position accounts for 0.02% of the portfolio, ranked #722.

Goldman Sachs first reported a position in PODD in Q2 2013 and has held it in 52 quarters since. The position peaked at $311M in Q2 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Goldman Sachs held 863,916 shares of Insulet worth $181M as of Q1 2026.
  • Goldman Sachs bought 95,581 Insulet shares in Q1 2026, an estimated $24M.
  • Insulet made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #722 holding.
  • Goldman Sachs first reported a position in Insulet in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Insulet position peaked at $311M in Q2 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.